Julian Clement Hirst

Panmure Gordon (UK) Ltd. (PGL) is the stockbroking subsidiary of Panmure Gordon & Co. Ltd. in Great Britain. Headquartered in London, the firm was founded in 2003 and provides corporate finance advice, distributes and trades securities and produces investment research to UK small and mid-cap corporates and investment companies. PGL has access to capital markets via a range of equity and equity-linked products such as IPOs, accelerated book buildings, placings, rights issues, and bought deals. The firm's institutional equities department provides UK-focused research, sales and trading services to institutional investors in the UK, US and Europe.

Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom.